0.9256
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Pds Biotechnology Corporation Borsa (PDSB) Ultime notizie
The growth track for PDS Biotechnology Corporation (PDSB) has changed recently - setenews.com
Tools to assess PDS Biotechnology Corporation’s risk profile2025 Dividend Review & Fast Gaining Stock Strategy Reports - newser.com
Will PDS Biotechnology Corporation stock go up soonEarnings Overview Summary & Free High Accuracy Swing Entry Alerts - newser.com
Is PDS Biotechnology Corporation stock positioned for long term growthJuly 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - newser.com
Will PDS Biotechnology Corporation stock reach all time highs in 2025Earnings Growth Summary & Safe Entry Trade Signal Reports - newser.com
Why PDS Biotechnology Corporation stock is recommended by analystsJuly 2025 Movers & Precise Swing Trade Entry Alerts - newser.com
Is PDS Biotechnology Corporation stock entering bullish territoryTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Is PDS Biotechnology Corporation stock a good choice for value investorsJuly 2025 PreEarnings & Consistent Profit Trading Strategies - newser.com
Earnings visualization tools for PDS Biotechnology CorporationTrend Reversal & Reliable Trade Execution Plans - newser.com
Multi factor analysis applied to PDS Biotechnology CorporationM&A Rumor & Real-Time Volume Trigger Notifications - newser.com
What machine learning models say about PDS Biotechnology CorporationCPI Data & Fast Moving Trade Plans - newser.com
PDS Biotechnology Stock Logs Best Session In 2 Months After FDA Fast-Track Push For Cancer Drug — Retail Bets On Early Approval - Stocktwits
Building trade automation scripts for PDS Biotechnology CorporationTrade Exit Report & Safe Capital Growth Tips - newser.com
PDS Biotechnology Seeks Accelerated FDA Pathway for Cancer Therapy - AD HOC NEWS
What dividend safety score for PDS Biotechnology Corporation stockTrade Volume Summary & Fast Moving Market Watchlists - newser.com
PDS Biotechnology Corporation’s volatility index tracking explainedRate Hike & Low Drawdown Investment Strategies - newser.com
New Clinical and Translational Data on PDS Biotechnology’s Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting - The Manila Times
PDS Biotechnology Corporation Announces New Clinical and Translational Data on Pds0101 and Pds01adc to Be Presented At the 2025 Society for Immunotherapy of Cancer Annual Meeting - MarketScreener
PDS Biotech stock soars after seeking expedited approval pathway for cancer drug - Investing.com India
PDS Biotech to seek expedited approval pathway for PDS0101 in HPV16-positive head and neck cancer - MarketScreener
PDS Biotechnology Corporation Seeks Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer Following Promising VERSATILE-002 Trial Results - Quiver Quantitative
PDSB seeks FDA meeting to explore expedited path for PDS0101 - Stock Titan
39.3-month mOS seen with PDS0101 as PDS Biotech (NASDAQ: PDSB) seeks FDA expedited path - Stock Titan
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):